Skip to main content

Advertisement

Log in

Unchained melody: revisiting the estimation of SF-6D values

  • Original Paper
  • Published:
The European Journal of Health Economics Aims and scope Submit manuscript

Abstract

Purpose

In the original SF-6D valuation study, the analytical design inherited conventions that detrimentally affected its ability to predict values on a quality-adjusted life year (QALY) scale. Our objective is to estimate UK values for SF-6D states using the original data and multi-attribute utility (MAU) regression after addressing its limitations and to compare the revised SF-6D and EQ-5D value predictions.

Methods

Using the unaltered data (611 respondents, 3503 SG responses), the parameters of the original MAU model were re-estimated under three alternative error specifications, known as the instant, episodic, and angular random utility models. Value predictions on a QALY scale were compared to EQ-5D3L predictions using the 1996 Health Survey for England.

Results

Contrary to the original results, the revised SF-6D value predictions range below 0 QALYs (i.e., worse than death) and agree largely with EQ-5D predictions after adjusting for scale. Although a QALY is defined as a year in optimal health, the SF-6D sets a higher standard for optimal health than the EQ-5D-3L; therefore, it has larger units on a QALY scale by construction (20.9 % more).

Conclusions

Much of the debate in health valuation has focused on differences between preference elicitation tasks, sampling, and instruments. After correcting errant econometric practices and adjusting for differences in QALY scale between the EQ-5D and SF-6D values, the revised predictions demonstrate convergent validity, making them more suitable for UK economic evaluations compared to original estimates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Brazier, J., Usherwood, T., Harper, R.K.T.: Deriving a preference-based single index from the UK SF-36 health survey. J. Clin. Epidemiol. 51, 1115–1128 (1998)

    Article  CAS  PubMed  Google Scholar 

  2. EuroQol Group: EQ-5D products: EQ-5D-5L. http://www.euroqol.org/eq-5d/eq-5d-products.html. Accessed 7 Oct 2014

  3. Torrance, G.W.: Social preferences for health states: an empirical evaluation of three measurement techniques. Socio Econ. Plan. Sci. 10, 129–136 (1976)

    Article  Google Scholar 

  4. Torrance, G.W., Thomas, W.H., Sackett, D.L.: A utility maximization model for evaluation of health care programs. Health Serv. Res. 7(2), 118–133 (1972)

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Tsuchiya, A., Ikeda, S., Ikegami, N., Nishimura, S., Sakai, I., Fukuda, T., Hamashima, C., Hisashige, A., Tamura, M.: Estimating an EQ-5D population value set: the case of Japan. Health Econ. 11(4), 341–353 (2002)

    Article  PubMed  Google Scholar 

  6. Brazier, J., Roberts, J., Deverill, M.: The estimation of a preference-based measure of health from the SF-36. J. Health Econ. 21(2), 271–292 (2002)

    Article  PubMed  Google Scholar 

  7. Lamers, L.M.: The transformation of utilities for health states worse than death: consequences for the estimation of EQ-5D value sets. Med. Care 45(3), 238–244 (2007)

    Article  PubMed  Google Scholar 

  8. Patrick, D.L., Starks, H.E., Cain, K.C., Uhlmann, R.F., Pearlman, R.A.: Measuring preferences for health states worse than death. Med. Decis. Mak. 14(1), 9–18 (1994)

    Article  CAS  Google Scholar 

  9. Gudex, C.: Time trade-off user manual: props and self-completion methods. In: Report of the Centre for Health Economics. University of York, York (1994)

  10. Williams, A.: A measurement and valuation of health: a chronicle. In: Discussion paper, vol. 136, pp. 1–53. Centre for Health Economics, York Health Economics Consortium, NHS Centre for Reviews & Dissemination, University of York, York, (1995)

  11. Craig, B.M., Busschbach, J.J.: The episodic random utility model unifies time trade-off and discrete choice approaches in health state valuation. Popul. Health Metr. 7(1), 3 (2009)

    Article  PubMed  PubMed Central  Google Scholar 

  12. Craig, B.M., Busschbach, J.J.: Toward a more universal approach in health valuation. Health Econ. 20(7), 864–875 (2011)

  13. Craig, B.M., Oppe, M.: From a different angle: a novel approach to health valuation. Soc. Sci. Med. 70(2), 169–174 (2010)

  14. Brazier, J., Roberts, J., Tsuchiya, A., Busschbach, J.: A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ. 13(9), 873–884 (2004)

    Article  PubMed  Google Scholar 

  15. Hatoum, H.T., Brazier, J.E., Akhras, K.S.: Comparison of the HUI3 with the SF-36 preference based SF-6D in a clinical trial setting. Value Health 7(5), 602–609 (2004)

    Article  PubMed  Google Scholar 

  16. Kharroubi, S.A., Brazier, J.E., Roberts, J., O’Hagan, A.: Modelling SF-6D health state preference data using a nonparametric Bayesian method. J. Health Econ. 26(3), 597–612 (2007)

    Article  PubMed  Google Scholar 

  17. Ware Jr, J.E., Gandek, B., Kosinski, M., Aaronson, N.K., Apolone, G., Brazier, J., Bullinger, M., Kaasa, S., Leplege, A., Prieto, L., Sullivan, M., Thunedborg, K.: The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International quality of life assessment. J. Clin. Epidemiol. 51(11), 1167–1170 (1998)

    Article  PubMed  Google Scholar 

  18. StataCorp.: Stata Statistical Software: Release 10. In. StataCorp LP, College Station, Texas (2008)

  19. Efron, B., Tibshirani, R.: An introduction to the bootstrap. Chapman & Hall, New York (1993)

    Book  Google Scholar 

  20. Lin, L.I.: A concordance correlation coefficient to evaluate reproducibility. Biometrics 45(1), 255–268 (1989)

    Article  CAS  PubMed  Google Scholar 

  21. Craig, B.M., Brown, D.S., Reeve, B.B.: The value adults place on child health and functional status. Value Health J. Int. Soc. Pharmacoecon. Outcomes Res. 18(4), 449–456 (2015)

    Article  Google Scholar 

  22. Craig, B.M., Pickard, A.S., Stolk, E., Brazier, J.E.: US valuation of the SF-6D. Med. Decis. Mak. 33(6), 793–803 (2013)

    Article  Google Scholar 

  23. Craig, B.M., Reeve, B.B., Brown, P.M., Cella, D., Hays, R.D., Lipscomb, J., Simon Pickard, A., Revicki, D.A.: US valuation of health outcomes measured using the PROMIS-29. Value Health J. Int. Soc. Pharmacoecon. Outcomes Res. 17(8), 846–853 (2014)

    Article  Google Scholar 

  24. Menzies, N.A., Salomon, J.A.: Non-monotonicity in the episodic random utility model. Health Econ. 20(12), 1523–1531 (2011)

    Article  PubMed  Google Scholar 

  25. Bansback, N., Brazier, J., Tsuchiya, A.: A comparison of using discrete choice experiments and the time trade-off to value health states for quality adjusted life years. Paper presented at the EuroQol Group Meeting, Paris, France, October 2009

  26. Craig, B.M.: Arctangent model for conjoint analysis. Paper presented at the 2nd annual health econometrics workshop, University of Michigan, Ann Arbor, 1–2, Oct 2010

  27. Donaldson, C., Baker, R., Mason, H., Jones-Lee, M., Lancsar, E., Wildman, J., Bateman, I., Loomes, G., Robinson, A., Sugden, R., Prades, J., Ryan, M., Shackley, P., Smith, R.: The social value of a QALY: raising the bar or barring the raise? BMC Health Serv. Res. 11(1), 8 (2011)

    Article  PubMed  PubMed Central  Google Scholar 

  28. Lancsar, E., Wildman, J., Donaldson, C., Ryan, M., Baker, R.: Deriving distributional weights for QALYs through discrete choice experiments. J. Health Econ. 30(2), 466–478 (2011)

    Article  PubMed  Google Scholar 

  29. Baker, R., Bateman, I., Donaldson, C., Jones-Lee, M., Lancsar, E., Loomes, G., Mason, H., Odejar, M., Pinto Prades, J., Robinson, A., Ryan, M., Shackley, P., Smith, R., Sugden, R., Wildma, J.: t.S.R.: weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the social value of a QALY project. Health Technol. Assess. 14(27), 162 (2010)

    Article  Google Scholar 

  30. Whitehurst, D.G., Norman, R., Brazier, J.E., Viney, R.: Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises. Value Health 17(5), 570–577 (2014)

    Article  PubMed  Google Scholar 

  31. Dolan, P.: Modeling valuations for EuroQol health states. Med. Care 35(11), 1095–1108 (1997)

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

Funding support for this research was provided by the National Institutes of Health (NIH) Infrastructure grant, “Developing Information Infrastructure Focused on Cancer Comparative Effectiveness Research” (RC2-CA148332; PI: Fenstermacher); and Dr. Craig’s National Cancer Institute (NCI) Career Development Award (K25 -CA122176).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Benjamin M. Craig.

Ethics declarations

Conflict of interest

The author has no potential conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Craig, B.M. Unchained melody: revisiting the estimation of SF-6D values. Eur J Health Econ 17, 865–873 (2016). https://doi.org/10.1007/s10198-015-0727-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10198-015-0727-4

Keywords

JEL Classification

Navigation